Encompass Health Co. (NYSE:EHC) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 18.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 367,598 shares of the company's stock after buying an additional 57,130 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.36% of Encompass Health worth $33,948,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. Colonial Trust Co SC acquired a new position in shares of Encompass Health in the fourth quarter valued at about $29,000. Transce3nd LLC acquired a new position in shares of Encompass Health in the fourth quarter valued at about $40,000. CBIZ Investment Advisory Services LLC increased its holdings in shares of Encompass Health by 38.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock valued at $42,000 after purchasing an additional 127 shares during the period. V Square Quantitative Management LLC increased its holdings in shares of Encompass Health by 43.8% in the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after purchasing an additional 177 shares during the period. Finally, Signaturefd LLC increased its holdings in shares of Encompass Health by 21.6% in the fourth quarter. Signaturefd LLC now owns 704 shares of the company's stock valued at $65,000 after purchasing an additional 125 shares during the period. 97.25% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have recently weighed in on EHC shares. Wall Street Zen raised Encompass Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, May 24th. Royal Bank of Canada increased their price objective on Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a report on Monday, April 28th. William Blair reissued an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Barclays raised their target price on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a report on Friday, April 25th. Finally, KeyCorp raised their target price on Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a report on Tuesday. Eight equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Buy" and an average price target of $122.71.

Insiders Place Their Bets

In other news, EVP John Patrick Darby sold 10,000 shares of the firm's stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total value of $1,147,900.00. Following the transaction, the executive vice president now owns 79,710 shares in the company, valued at $9,149,910.90. This trade represents a 11.15% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Mark J. Tarr sold 118,384 shares of the firm's stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total value of $14,387,207.52. Following the completion of the transaction, the chief executive officer now owns 527,070 shares in the company, valued at approximately $64,054,817.10. This trade represents a 18.34% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 132,663 shares of company stock worth $16,034,082. 2.00% of the stock is owned by corporate insiders.

Encompass Health Price Performance

EHC stock traded up $1.00 during mid-day trading on Friday, reaching $121.01. 977,100 shares of the company's stock were exchanged, compared to its average volume of 702,178. The company has a market cap of $12.20 billion, a price-to-earnings ratio of 27.13, a price-to-earnings-growth ratio of 2.31 and a beta of 0.91. The stock's 50 day moving average is $109.93 and its 200 day moving average is $102.01. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. Encompass Health Co. has a 12-month low of $82.74 and a 12-month high of $122.09.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.19 by $0.18. The company had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Encompass Health's revenue for the quarter was up 10.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.12 earnings per share. On average, research analysts expect that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.56%. Encompass Health's dividend payout ratio is currently 14.05%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.